NeuroMetrix Shareholders Equity Per Share from 2010 to 2024

NURO Stock  USD 3.65  0.08  2.24%   
NeuroMetrix Shareholders Equity Per Share yearly trend continues to be very stable with very little volatility. Shareholders Equity Per Share is likely to drop to 18.32. During the period from 2010 to 2024, NeuroMetrix Shareholders Equity Per Share quarterly data regression pattern had range of 45.3 K and standard deviation of  10,509. View All Fundamentals
 
Shareholders Equity Per Share  
First Reported
2010-12-31
Previous Quarter
19.28167929
Current Value
18.32
Quarterly Volatility
10.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NeuroMetrix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NeuroMetrix main balance sheet or income statement drivers, such as Depreciation And Amortization of 52.9 K, Interest Expense of 278 K or Total Revenue of 5.6 M, as well as many exotic indicators such as Price To Sales Ratio of 0.6, Dividend Yield of 21.96 or PTB Ratio of 0.18. NeuroMetrix financial statements analysis is a perfect complement when working with NeuroMetrix Valuation or Volatility modules.
  
This module can also supplement various NeuroMetrix Technical models . Check out the analysis of NeuroMetrix Correlation against competitors.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.

Latest NeuroMetrix's Shareholders Equity Per Share Growth Pattern

Below is the plot of the Shareholders Equity Per Share of NeuroMetrix over the last few years. It is NeuroMetrix's Shareholders Equity Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NeuroMetrix's overall financial position and show how it may be relating to other accounts over time.
Shareholders Equity Per Share10 Years Trend
Slightly volatile
   Shareholders Equity Per Share   
       Timeline  

NeuroMetrix Shareholders Equity Per Share Regression Statistics

Arithmetic Mean(2,129)
Coefficient Of Variation(493.65)
Mean Deviation5,019
Median29.49
Standard Deviation10,509
Sample Variance110.4M
Range45.3K
R-Value0.36
Mean Square Error103.5M
R-Squared0.13
Significance0.19
Slope845.58
Total Sum of Squares1.5B

NeuroMetrix Shareholders Equity Per Share History

2024 18.32
2023 19.28
2022 26.21
2021 36.34
2020 13.93
2019 20.91
2018 4.39

About NeuroMetrix Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include NeuroMetrix income statement, its balance sheet, and the statement of cash flows. NeuroMetrix investors use historical funamental indicators, such as NeuroMetrix's Shareholders Equity Per Share, to determine how well the company is positioned to perform in the future. Although NeuroMetrix investors may use each financial statement separately, they are all related. The changes in NeuroMetrix's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NeuroMetrix's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on NeuroMetrix Financial Statements. Understanding these patterns can help to make the right decision on long term investment in NeuroMetrix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Shareholders Equity Per Share 19.28  18.32 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NeuroMetrix in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NeuroMetrix's short interest history, or implied volatility extrapolated from NeuroMetrix options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether NeuroMetrix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeuroMetrix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurometrix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurometrix Stock:
Check out the analysis of NeuroMetrix Correlation against competitors.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for NeuroMetrix Stock analysis

When running NeuroMetrix's price analysis, check to measure NeuroMetrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroMetrix is operating at the current time. Most of NeuroMetrix's value examination focuses on studying past and present price action to predict the probability of NeuroMetrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroMetrix's price. Additionally, you may evaluate how the addition of NeuroMetrix to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is NeuroMetrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.27)
Revenue Per Share
5.664
Quarterly Revenue Growth
(0.29)
Return On Assets
(0.19)
Return On Equity
(0.30)
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.